Acadia Pharmaceuticals (ACAD) Interest & Investment Income (2010 - 2013)
Acadia Pharmaceuticals' (ACAD) quarterly Interest & Investment Income came in at $41000.0 in Q1 2013, up 215.38% year-on-year from $13000.0 in Q1 2012, and up 355.56% quarter-over-quarter from $9000.0 in Q4 2012.
Acadia Pharmaceuticals (ACAD) Interest & Investment Income (2010 - 2013) Analysis & Trends
Acadia Pharmaceuticals' Interest & Investment Income history runs 4 years deep, the most recent figure standing at $41000.0 for Q1 2013.
- On a quarterly basis, Interest & Investment Income rose 215.38% year-over-year to $41000.0 in Q1 2013; TTM through Mar 2013 was $65000.0, a 9.72% decrease from a year earlier, with the FY2012 full-year figure at $37000.0, down 57.47% from the prior year.
- Interest & Investment Income grew to $41000.0 in Q1 2013 per ACAD's latest filing, from $9000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $41000.0 in Q1 2013 and bottomed at $5000.0 in Q3 2012.
- The 4-year median for Interest & Investment Income is $13500.0 (2011), against an average of $16666.7.
- Across the five-year window, Interest & Investment Income soared 250.0% in 2011 and sank 70.59% in 2012, its largest moves.
- Year by year, Interest & Investment Income stood at $12000.0 in 2010, then gained by 16.67% to $14000.0 in 2011, then slumped by 35.71% to $9000.0 in 2012, then surged by 355.56% to $41000.0 in 2013.
- Per Business Quant, the three latest ACAD Interest & Investment Income figures stand at $41000.0 (Q1 2013), $9000.0 (Q4 2012), and $5000.0 (Q3 2012).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Acadia Pharmaceuticals | 4.23 Bn | 3.38 Bn | 243.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 41,000.00 |
| Dec 31, 2012 | 9,000.00 |
| Sep 30, 2012 | 5,000.00 |
| Jun 30, 2012 | 10,000.00 |
| Mar 31, 2012 | 13,000.00 |
| Dec 31, 2011 | 14,000.00 |
| Sep 30, 2011 | 17,000.00 |
| Jun 30, 2011 | 28,000.00 |
| Mar 31, 2011 | 28,000.00 |
| Dec 31, 2010 | 12,000.00 |
| Sep 30, 2010 | 15,000.00 |
| Jun 30, 2010 | 8,000.00 |